The Need of a Hybrid Approach for the Treatment of Atrial Fibrillation

Authors

  • Gianluigi Bisleri
  • Antonio Curnis
  • Tomaso Bottio
  • Giosuè Mascioli
  • Claudio Muneretto

DOI:

https://doi.org/10.1532/HSF98.20051125

Abstract

Atrial fibrillation represents nowadays one of the most important burdens in the field of arrhythmia. Albeit often inadequate, medical treatment is still considered the "first-step" approach. Non-pharmacological strategies, either surgical or interventional, recently gained an increasing interest among both cardiac surgeons and electrophysiologists. From the surgical standpoint, the introduction of different energy sources and the development of minimally invasive techniques as an alternative to the original "cut-and-sew" technique allowed a new dawn in the surgical treatment of atrial fibrillation. In the meanwhile, electrophysiologists developed more complex ablation systems that allowed the creation of linear lesions, similar to the surgical ones, while mapping the atria with three-dimensional (3D) navigation systems. Nevertheless, the success rate in terms of sinus rhythm restoration was around 80%-85% in both fields. We foresee that the combination of the two approaches (i.e., surgical and percutaneous approach), in common hybrid approach, will allow a substantial reform for the definitive cure of atrial fibrillation, either paroxysmal or permanent, providing the highest success rates along with the best care for patients' health.

References

Todd DM, Skanes AC, Guiraudon G, et al. 2003. Role of the posterior left atrium and pulmonary veins in human lone atrial fibrillation. Circulation 108:3108-14.nArgenziano M, Williams MR. 2003. Robotic atrial septal defect repair and endoscopic treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 15(2):130-40.nWilliams MR. 2002. A review of the methods of atrial tissue ablation. Heart Surg Forum : HSF Reviews 1:7-8.nWong T, Markides V, Peters NS, Davies DW. 2004. Percutaneous pulmonary vein cryoablation to treat atrial fibrillation. J Interv Card Electrophysiol 11:117-26.nAllessie MA. 1999. Atrial fibrillation-induced electrical remodeling in humans: what is the next step? Cardiovasc Res 44(1):10-2.nAl-Saady NM, Obel OA, Camm AJ. 1999. Left atrial appendage: structure, function, and role in thromboembolism. Heart 82:547-55.nHaissaguerre M, Shah DC, Jais P. 2000. Mapping-guided ablation of pulmonary veins to cure atrial fibrillation. Am J Cardiol 86(9 Suppl 1): K9-K19.nHindricks G, Kottkamp H. 2001. Simultaneous noncontact mapping of left atrium in patients with paroxysmal atrial fibrillation. Circulation 104(3):297-303.nGaita F, Riccardi R. 2003. Non-pharmacological treatment of atrial fibrillation. Ital Heart J 4:745-54.nBenjamin EJ, Wolf PA, D'Agostino RB. 1998. Impact of atrial fibrillation on the risk of death - the Framingham Heart Study. Circulation 98:946-52.nCain ME. 2002. Atrial fibrillation -- rhythm or rate control. N Engl J Med 347:1822-3.nCox JL, Schuessler RB, Cain ME, et al. 1989. Surgery for atrial fibrillation. Semin Thorac Cardiovasc Surg 1:67-73.nCox JL, Ad N, Palazzo T. 1999. Impact of the Maze procedure on the stroke rate in patients with atrial fibrillation. J Thorac Cardiovasc Surg 118:838-40.nKalil RA, Lima GG, Leiria TL, et al. 2002. Simple surgical isolation of pulmonary veins for treating secondary atrial fibrillation in mitral valve disease. Ann Thorac Surg 73:1169-73.nKnaut M, Tugtekin SM, Spitzer S, Gulielmos V. 2000. Combined atrial fibrillation and mitral valve surgery using microwave technology. Semin Thorac Cardiovasc Surg 14:226-31.nKnaut M, Tugtekin SM, Matschke K. 2004. Pulmonary vein isolation by microwave energy ablation in patients with permanent atrial fibrillation. J Card Surg 19:211-5.nKottkamp H, Tanner H, Kobza R, et al. 2004. Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions. J Am Coll Cardiol 44:869-77.nLammers WJ, Schalij MJ, Kirchhof CJ, Allessie MA. 1990. Quantification of spatial inhomogeneity in conduction and initiation of reentrant atrial arrhythmias. Am J Physiol 259(4 Pt 2):H1254-63.nLindsay BD. 1996. Obliteration of the left atrial appendage: A concept worth testing. Ann Thorac Surg 61:515.nLundstrom T, Ryden L. 1998. Chronic atrial fibrillation. Long-term results of direct current conversion. Acta Med Scand 223:53-9.nMaessen JG, Nijs JF, Smeets JL, Vainer J, Mochtar B. 2002. Beating-heart surgical treatment of atrial fibrillation with microwave ablation. Ann Thorac Surg 74:S1307-11.nMarcus GM, Sung RJ. 2001. Antiarrhythmic agents in facilitating electrical cardioversion of atrial fibrillation and promoting maintenance of sinus rhythm. Cardiology 95:1-8.nMelo J, Adragao P, Neves J, et al. 2000. Endocardial and epicardial radiofrequency ablation in the treatment of atrial fibrillation with a new intra-operative device. Eur J Cardiothorac Surg 18:182-6.nOdell JA, Blackshear JL, Davies E, et al. 1996. Thoracoscopic obliteration of the left atrial appendage: Potential for stroke reduction? Ann Thorac Surg 61:565-9.nStollberger C, Schneider B, Finsterer J. 2003. Elimination of the left atrial appendage to prevent stroke or embolism? Chest 124:2356-62. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. 2002. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825-33.nThe National Heart, Lung, and Blood Institute Working Group on Atrial Fibrillation. 1993. Atrial fibrillation: current understandings and research imperatives. J Am Coll Cardiol 22:1830-4.nPappone C, Rosanio S, Augello G, et al. 2003. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation. J Am Coll Cardiol 42:185-97.nSievert H, Lesh MD, Trepels T, et al. 2002. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation 105:1887-9.nPappone C, Rosanio S, Oreto G, et al. 2000. Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation 102(21):2619-28.nPennec PY, Jobic Y, Blanc JJ, Bezon E, Barra JA. 2003. Assessment of different procedures for surgical left atrial appendage exclusion. AnnnThorac Surg 76:2168-9.nSaltman AE, Rosenthal LS, Francalancia NA, Lahey SJ. 2003. A completely endoscopic approach to microwave ablation for atrial fibrillation. Heart Surg Forum 6(3):38-41.nOlshansky B, Rosenfeld LE, Warner AL, et al. 2004. The atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study: approaches to control rate in atrial fibrillation. J Am Coll Cardiol 43:1201-8.nChen SA, Hsieh MH, Tai CT, et al. 1999. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 100:1879-86.nDoll N, Borger MA, Fabricius A, et al. 2003. Esophageal perforation during left atrial radiofrequency ablation: Is the risk too high? J Thorac Cardiovasc Surg 125:836-42.nFeinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. 1995. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 155:469-73.nHaissaguerre M, Jais P, Shah DC, et al. 1998. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659-66.nJongbloed MR, Schalij MJ, Poelmann RE, 2004. 2004. Embryonic conduction tissue: a spatial correlation with adult arrhythmogenic areas. J Cardiovasc Electrophysiol 15(3):349-55.nArnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG. 1992. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol 19:851-5.nBisleri G, Manzato A, Argenziano M, Vigilance DW, Muneretto C. 2005. Thoracoscopic epicardial pulmonary vein ablation for lone paroxysmal atrial fibrillation. Europace 7:145-8.nBlom NA, Gittenberger-de Groot AC, Jongeneel TH, DeRuiter MC, Poelmann RE, Ottenkamp J. 2001. Normal development of the pulmonary veins in human embryos and formulation of a morphogenetic concept for sinus venosus defects. Am J Cardiol 87:305-9.n

Published

2005-08-29

How to Cite

Bisleri, G., Curnis, A., Bottio, T., Mascioli, G., & Muneretto, C. (2005). The Need of a Hybrid Approach for the Treatment of Atrial Fibrillation. The Heart Surgery Forum, 8(5), E326-E330. https://doi.org/10.1532/HSF98.20051125

Issue

Section

Articles

Most read articles by the same author(s)